Ana Paula Azambuja
Federal University of Paraná
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ana Paula Azambuja.
Circulation Research | 2010
Ana Paula Azambuja; Victor Portillo-Sánchez; Mariliza V. Rodrigues; Samantha Vieira Omae; Deborah Schechtman; Bryan E. Strauss; Eugenia Costanzi-Strauss; José Eduardo Krieger; José M. Pérez-Pomares; José Xavier-Neto
Rationale: Major coronary vessels derive from the proepicardium, the cellular progenitor of the epicardium, coronary endothelium, and coronary smooth muscle cells (CoSMCs). CoSMCs are delayed in their differentiation relative to coronary endothelial cells (CoEs), such that CoSMCs mature only after CoEs have assembled into tubes. The mechanisms underlying this sequential CoE/CoSMC differentiation are unknown. Retinoic acid (RA) is crucial for vascular development and the main RA-synthesizing enzyme is progressively lost from epicardially derived cells as they differentiate into blood vessel types. In parallel, myocardial vascular endothelial growth factor (VEGF) expression also decreases along coronary vessel muscularization. Objective: We hypothesized that RA and VEGF act coordinately as physiological brakes to CoSMC differentiation. Methods and Results: In vitro assays (proepicardial cultures, cocultures, and RALDH2 [retinaldehyde dehydrogenase-2]/VEGF adenoviral overexpression) and in vivo inhibition of RA synthesis show that RA and VEGF act as repressors of CoSMC differentiation, whereas VEGF biases epicardially derived cell differentiation toward the endothelial phenotype. Conclusion: Experiments support a model in which early high levels of RA and VEGF prevent CoSMC differentiation from epicardially derived cells before RA and VEGF levels decline as an extensive endothelial network is established. We suggest this physiological delay guarantees the formation of a complex, hierarchical, tree of coronary vessels.
PLOS ONE | 2013
Cristiane S. Ferreira-Facio; Cristiane Bedran Milito; Vitor Botafogo; Marcela Fontana; Leandro S. Thiago; Elen Oliveira; Ariovaldo S. da Rocha-Filho; Fernando Werneck; Danielle Nunes Forny; Samuel Dekermacher; Ana Paula Azambuja; Sima Ferman; Paulo Antônio Silvestre de Faria; Marcelo G. P. Land; Alberto Orfao; Elaine Sobral da Costa
Pediatric cancer is a relatively rare and heterogeneous group of hematological and non-hematological malignancies which require multiple procedures for its diagnostic screening and classification. Until now, flow cytometry (FC) has not been systematically applied to the diagnostic work-up of such malignancies, particularly for solid tumors. Here we evaluated a FC panel of markers for the diagnostic screening of pediatric cancer and further classification of pediatric solid tumors. The proposed strategy aims at the differential diagnosis between tumoral vs. reactive samples, and hematological vs. non-hematological malignancies, and the subclassification of solid tumors. In total, 52 samples from 40 patients suspicious of containing tumor cells were analyzed by FC in parallel to conventional diagnostic procedures. The overall concordance rate between both approaches was of 96% (50/52 diagnostic samples), with 100% agreement for all reactive/inflammatory and non-infiltrated samples as well as for those corresponding to solid tumors (n = 35), with only two false negative cases diagnosed with Hodgkin lymphoma and anaplastic lymphoma, respectively. Moreover, clear discrimination between samples infiltrated by hematopoietic vs. non-hematopoietic tumor cells was systematically achieved. Distinct subtypes of solid tumors showed different protein expression profiles, allowing for the differential diagnosis of neuroblastoma (CD56hi/GD2+/CD81hi), primitive neuroectodermal tumors (CD271hi/CD99+), Wilms tumors (>1 cell population), rhabdomyosarcoma (nuMYOD1+/numyogenin+), carcinomas (CD45−/EpCAM+), germ cell tumors (CD56+/CD45−/NG2+/CD10+) and eventually also hemangiopericytomas (CD45−/CD34+). In summary, our results show that multiparameter FC provides fast and useful complementary data to routine histopathology for the diagnostic screening and classification of pediatric cancer.
Development | 2010
Hozana A. Castillo; Roberta M. Cravo; Ana Paula Azambuja; Marcos Simões-Costa; Sylvia Sura-Trueba; Jose Gonzalez; Esfir Slonimsky; Karla Almeida; José G. Abreu; Marcio Aa Almeida; Tiago José Paschoal Sobreira; Saulo Henrique Pires de Oliveira; Paulo S. L. Oliveira; Iskra A. Signore; Alicia Colombo; Miguel L. Concha; Tatjana S. Spengler; Marianne Bronner-Fraser; Marcelo A. Nobrega; Nadia Rosenthal; José Xavier-Neto
Comparative studies of the tetrapod raldh2 (aldh1a2) gene, which encodes a retinoic acid (RA) synthesis enzyme, have led to the identification of a dorsal spinal cord enhancer. Enhancer activity is directed dorsally to the roof plate and dorsal-most (dI1) interneurons through predicted Tcf- and Cdx-homeodomain binding sites and is repressed ventrally via predicted Tgif homeobox and ventral Lim-homeodomain binding sites. Raldh2 and Math1/Cath1 expression in mouse and chicken highlights a novel, transient, endogenous Raldh2 expression domain in dI1 interneurons, which give rise to ascending circuits and intraspinal commissural interneurons, suggesting roles for RA in the ontogeny of spinocerebellar and intraspinal proprioceptive circuits. Consistent with expression of raldh2 in the dorsal interneurons of tetrapods, we also found that raldh2 is expressed in dorsal interneurons throughout the agnathan spinal cord, suggesting ancestral roles for RA signaling in the ontogenesis of intraspinal proprioception.
Clinical, Cosmetic and Investigational Dermatology | 2016
Thiago de Farias Pires; Ana Paula Azambuja; Andrea R. V. R. Horimoto; Mary Sanae Nakamura; Rafael de Oliveira Alvim; José Eduardo Krieger; Alexandre C. Pereira
Background The stratum corneum (SC) has important functions as a bound-water modulator and a primary barrier of the human skin from the external environment. However, no large epidemiological study has quantified the relative importance of different exposures with regard to these functional properties. In this study, we have studied a large sample of individuals from the Brazilian population in order to understand the different relationships between the properties of SC and a number of demographic and self-perceived variables. Methods One thousand three hundred and thirty-nine individuals from a rural Brazilian population, who were participants of a family-based study, were submitted to a cross-sectional examination of the SC moisture by capacitance using the Corneometer® CM820 and investigated regarding environmental exposures, cosmetic use, and other physiological and epidemiological measurements. Self-perception-scaled questions about skin conditions were also applied. Results We found significant associations between SC moisture and sex, age, high sun exposure, and sunscreen use frequency (P<0.025). In specific studied sites, self-reported race and obesity were also found to show significant effects. Dry skin self-perception was also found to be highly correlated with the objective measurement of the skin. Other environmental effects on SC moisture are also reported.
BMJ Open | 2016
Kieren J. Egan; Malcolm von Schantz; André B. Negrão; Hadassa Campos Santos; Andrea R. V. R. Horimoto; Nubia Esteban Duarte; Guilherme C Gonçalves; Júlia Maria Pavan Soler; Mariza de Andrade; Geraldo Lorenzi-Filho; Homero Vallada; Tâmara P. Taporoski; Mario Pedrazzoli; Ana Paula Azambuja; Camila Maciel de Oliveira; Rafael de Oliveira Alvim; José Eduardo Krieger; Alexandre C. Pereira
Purpose Cardiovascular disease (CVD) is a major challenge to global health. The same epidemiological transition scenario is replayed as countries develop, but with variations based on environment, culture and ethnic mixture. The Baependi Heart Study was set up in 2005 to develop a longitudinal family-based cohort study that reflects on some of the genetic and lifestyle-related peculiarities of the Brazilian populations, in order to evaluate genetic and environmental influences on CVD risk factor traits. Participants Probands were recruited in Baependi, a small rural town in the state of Minas Gerais, Brazil, following by first-degree and then increasingly more distant relatives. The first follow-up wave took place in 2010, and the second in 2016. At baseline, the study evaluated 1691 individuals across 95 families. Cross-sectional data have been collected for 2239 participants. Findings to date Environmental and lifestyle factors and measures relevant to cardiovascular health have been reported. Having expanded beyond cardiovascular health outcomes, the phenotype datasets now include genetics, biochemistry, anthropometry, mental health, sleep and circadian rhythms. Many of these have yielded heritability estimates, and a shared genetic background of anxiety and depression has recently been published. In spite of universal access to electricity, the population has been found to be strongly shifted towards morningness compared with metropolitan areas. Future plans A new follow-up, marking 10 years of the study, is ongoing in 2016, in which data are collected as in 2010 (with the exception of the neuropsychiatric protocol). In addition to this, a novel questionnaire package collecting information about intelligence, personality and spirituality is being planned. The data set on circadian rhythms and sleep will be amended through additional questionnaires, actimetry, home sleep EEG recording and dim light melatonin onset (DLMO) analysis. Finally, the anthropometric measures will be expanded by adding three-dimensional facial photography, voice recording and anatomical brain MRI.
Revista Brasileira De Hematologia E Hemoterapia | 2015
Ana Paula Azambuja; Mariester Malvezzi; M.A. Bitencourt; M.M. Oliveira; L. Medeiros; Ricardo Pasquini
Background Paroxysmal nocturnal hemoglobinuria is an acquired chronic hemolytic anemia, which often manifests as peripheral blood cytopenias and thrombosis. Objective The aim of this study is to describe a Brazilian population of paroxysmal nocturnal hemoglobinuria patients. Methods One hundred and three paroxysmal nocturnal hemoglobinuria cases were retrospectively reviewed and the clinical presentation, thrombosis, survival, and clone size were assessed. Diagnosis was established by flow cytometry. Results Fifty-two male and 51 female patients with a median age of 24.1 years (5.5–62 years) were studied. Clinical symptoms included hemoglobinuria (18.4%), infection (46.6%) and thrombosis (16.5%), and 80.6% had pancytopenia. Patients were classified as classic paroxysmal nocturnal hemoglobinuria (10), paroxysmal nocturnal hemoglobinuria with aplastic anemia (39), and paroxysmal nocturnal hemoglobinuria with subclinical features and aplastic anemia (54). There were significant differences in terms of median age, size of clone, clinical symptoms, and peripheral blood cell counts between the three subcategories. The clone size in erythrocytes and granulocytes were respectively 0.04% (range: 0–18%) and 7.3% (range: 0.3–68.7%) in patients with subclinical features and aplastic anemia, 15.8% (range: 0–99.7%) and 63.0% (range: 1.7–99.8%) in patients with aplastic anemia alone, and 82.2% (range: 0–99.85%) and 98.0% (81.3–100.0%) in Classic disease. Statistical differences were identified for platelets (p-value = 0.001), lactate dehydrogenase (p-value = 0.002) and the clone size (p-value < 0.001) in patients who suffered thrombotic events compared to those who did not. Overall survival was 81.7%, with patients with subclinical features and aplastic anemia having lower overall survival (76.5%). Conclusion This retrospective review of 103 patients over an 11-year period represents the largest collection of paroxysmal nocturnal hemoglobinuria cases from a single center in Brazil. Flow cytometry showed that a larger clone was associated with classical symptoms and increased risk of thrombosis, even in patients with bone marrow failure, whereas a smaller clone was associated with bone marrow aplasia.
Jornal Brasileiro De Patologia E Medicina Laboratorial | 2015
Rodolfo Patussi Correia; Ana Carolina Apelle Bortolucci; Annelise C. W. Lopes; Alex Freire Sandes; Ana Paula Azambuja; Marta A. Viana; Maria M. Sales; Mihoko Yamamoto; Nydia Strachman Bacal
The Brazilian Group of Flow Cytometry (Grupo Brasileiro de Citometria de Fluxo [GBCFLUX]), founded on April 24, 2010, is composed of experts in flow cytometry (FC) area who have the common objective of contributing to technical and scientific advances in Brazilian clinical and research laboratories. Among GBCFLUX working groups, the Quality Control (QC) subcommittee is responsible for discussing data in the literature and contributes to the quality assurance of the pre-analytical, analytical and post-analytical process in FC. The QC subcommittees actions began through meetings and lectures, in which data from the literature were reviewed and discussed with all participating members of the GBCFLUX. In a second step, it was decided to draw up a text of technical and scientific consensus recommendations, informative and educative, for dissemination to all FC working groups in Brazil. To this effect, a questionnaire with objective responses was designed and sent to 35 recognized Brazilian institutions, in order to evaluate the QC profile of these institutions. Thus, the QC technical-scientific recommendations, which will be described in this updating article, are intended to ensure the process quality, technical standardization, and reproducibility of results in FC.
Revista Brasileira De Hematologia E Hemoterapia | 2008
Vaneuza Araujo Moreira Funke; D.C. Setubal; J. Ruiz; Ana Paula Azambuja; Denise H. Lima; Terezinha K. Kojo; Ricardo Pasquini
O mesilato de imatinibe e atualmente o tratamento de escolha para pacientes com Leucemia mieloide Cronica (LMC) recem-diagnosticados. Desde os primeiros estudos clinicos em 1998 ate o estudo IRIS, que comparou o uso em primeira linha de imatinibe com interferon + ara-C, esta droga vem se consolidando em seguranca e eficacia. Ainda ha, entretanto questionamentos sobre a melhor dose inicial, a identificacao dos pacientes que mais se beneficiariam e a melhor abordagem frente a respostas sub-otimas e resistencia. Os principais estudos clinicos publicados com mesilato de imatinibe sao revisados no presente artigo, e discutidos sob a perspectiva da realidade brasileira.
Revista Brasileira De Hematologia E Hemoterapia | 2011
Ana Paula Azambuja; Bárbara do Nascimento; Samuel Ricardo Comar; Gisele Loth; Lisandro Ribeiro; Carmem Bonfim; Mara Albonei Dudeque Pianovski; José Zanis Neto; Mariester Malvezzi
Chediak-Higashi Syndrome (CHS) is a rare autosomal recessive disorder, with fewer than 500 cases published over the last 20 years.(1) The clinical features of this syndrome include partial oculocutaneous albinism, photosensitivity, grayish hair and skin,(1,2) severe recurrent bacterial infections, bleeding diathesis and neurological manifestations (central and peripheral neuropathies, sensory loss, muscle weakness, cerebellar ataxia and cognitive impairment).(1,3)
Archive | 2018
Alexander R. Moise; Ângela M. Sousa Costa; Murilo Carvalho; Ana Paula Azambuja; José Xavier-Neto; Hozana A. Castillo
Abstract We discuss coronary ontogeny and function in an evolutionary framework. Coronary morphogenesis is old, appearing at the level of the first jawed vertebrates. After its origins, the presence or absence of coronaries seems to be dictated more in response to physical activity than due to phylogenetic origin. The major coronary vessels derive from the proepicardium, which is a cellular progenitor of the epicardium, coronary endothelium, and coronary smooth muscle cells. Here we review the basic notion that coronary development is a highly organized process, in which coronary endothelial differentiation and tubular morphogenesis precedes coronary smooth muscle cell differentiation and incorporation into true coronary vessels. Some years ago, we showed that these complex steps are orchestrated by retinoic acid and the vascular endothelial growth factor. We also examine new views on the origins of coronary vessels (i.e., the sinus venosus) and explore the potential of the epicardium in coronary and cardiac regeneration.